Elotuzumab

Elotuzumab, also known by the brand name Empliciti, is a specific medication used in the treatment of multiple myeloma. It is a targeted therapy that focuses on a protein called SLAMF7, which is found on your multiple myeloma cells and some of your body's immune cells. By attaching to this protein, elotuzumab helps your immune system better identify and manage the myeloma cells. This topic will provide information about how Elotuzumab works, what to expect during treatment, and how it may fit into your overall care plan.